| Title: | PAR PHARMACEUTICAL COMPANIES INC - DETAILED PRODUCT PIPELINE |
| Price: | $2,000.00 |
| Publication Date: | Mar 19, 2006 |
| Source: | LIFE SCIENCE ANALYTICS |
| Brief Excerpt: | ...Par Pharmaceutical Companies, Inc., a holding company, engages in the research, development, manufacture, and distribution of generic drugs in the United States. Its product line comprises generic prescription drugs consisting of ### products representing various dosage strengths for ## separate drugs. The company s generic drug products include central nervous system, cardiovascular, anti -inflammatory, gastrointestinal, and anti -infective treatments. Its products are manufactured principally in the solid oral dosage form consisting of tablets, caplets, and two -piece hard shell capsules. Par Pharmaceutical also distributes one oral suspension product and one product in the semisolid form of a cream. In addition, it designs and develops intermediate ingredients used in the production of finished products for the pharmaceutical industry. The company markets its products under the Par label primarily to wholesalers, retail drug store chains, managed health care providers, and... |
| Length: | 50 Pages |
| Company: | PAR PHARMACEUTICAL COMPANIES INC |
| Geographic Regions: | MID-ATLANTIC/MIDDLE ATLANTIC REGION, NORTH AMERICA, NEW YORK (STATE OF), UNITED STATES OF AMERICA |
| Format: | 
Adobe Acrobat
|
Looking For Something Else?
